IL117459A - Dna encoding human papillomavirus type 18 - Google Patents

Dna encoding human papillomavirus type 18

Info

Publication number
IL117459A
IL117459A IL11745996A IL11745996A IL117459A IL 117459 A IL117459 A IL 117459A IL 11745996 A IL11745996 A IL 11745996A IL 11745996 A IL11745996 A IL 11745996A IL 117459 A IL117459 A IL 117459A
Authority
IL
Israel
Prior art keywords
dna encoding
encoding human
human papillomavirus
papillomavirus type
type
Prior art date
Application number
IL11745996A
Other languages
English (en)
Other versions
IL117459A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL117459(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/409,122 external-priority patent/US5820870A/en
Priority claimed from US08/408,669 external-priority patent/US5840306A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL117459A0 publication Critical patent/IL117459A0/xx
Publication of IL117459A publication Critical patent/IL117459A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL11745996A 1995-03-22 1996-03-13 Dna encoding human papillomavirus type 18 IL117459A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/409,122 US5820870A (en) 1995-03-22 1995-03-22 Recombinant human papillomavirus type 18 vaccine
US08/408,669 US5840306A (en) 1995-03-22 1995-03-22 DNA encoding human papillomavirus type 18

Publications (2)

Publication Number Publication Date
IL117459A0 IL117459A0 (en) 1996-07-23
IL117459A true IL117459A (en) 2005-11-20

Family

ID=27020342

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11745996A IL117459A (en) 1995-03-22 1996-03-13 Dna encoding human papillomavirus type 18

Country Status (22)

Country Link
EP (2) EP1422294A1 (xx)
JP (1) JPH11502704A (xx)
KR (1) KR100430698B1 (xx)
CN (1) CN1100876C (xx)
AT (1) ATE259879T1 (xx)
AU (1) AU714533B2 (xx)
CA (1) CA2215834C (xx)
CZ (1) CZ291242B6 (xx)
DE (4) DE122007000025I1 (xx)
DK (1) DK0817851T5 (xx)
EA (1) EA001092B1 (xx)
ES (1) ES2213772T3 (xx)
FR (1) FR07C0023I2 (xx)
HU (1) HU223761B1 (xx)
IL (1) IL117459A (xx)
NL (3) NL300272I1 (xx)
NO (1) NO322254B1 (xx)
NZ (1) NZ305188A (xx)
PL (1) PL184022B1 (xx)
PT (1) PT817851E (xx)
SK (1) SK284281B6 (xx)
WO (1) WO1996029413A2 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
ZA982950B (en) 1997-04-08 1998-10-19 Merck & Co Inc Stabilized human papillomavirus formulations
PT973546E (pt) * 1997-04-08 2004-06-30 Merck & Co Inc Formulacoes estabilizadas de virus de papiloma humano
PL347472A1 (en) * 1998-08-14 2002-04-08 Merck & Co Inc Process for purifying human papillomavirus virus-like particles
AUPP765398A0 (en) 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
DK1150712T3 (da) 1999-02-05 2009-02-02 Merck & Co Inc Vaccineformuleringer mod human papillomavirus
FR2795074A1 (fr) * 1999-05-21 2000-12-22 Inst Nat Sante Rech Med Polypeptides transporteurs d'acides amines, et en particulier du glutamate, et procedes de criblage de composes inhibiteurs ou activateurs de l'activite de transport
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
US9364529B2 (en) 2007-04-29 2016-06-14 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Truncated L1 protein of human papillomavirus type 18
WO2008134934A1 (en) 2007-04-29 2008-11-13 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. A truncated l1 protein of human papillomavirus 16
CN101440373B (zh) * 2007-11-23 2012-09-05 上海泽润生物科技有限公司 一种截短型的18型人乳头状瘤病毒主要衣壳蛋白l1基因
JP2012530505A (ja) * 2009-06-25 2012-12-06 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規ヒトパピローマウイルス（ｈｐｖ）タンパク質構築物及びｈｐｖ疾患の予防におけるそれらの使用
CN103717741B (zh) * 2011-06-15 2016-04-13 中央大学校产学协力团 用于提高人乳头瘤病毒l1蛋白产量的方法
JP2015514696A (ja) 2012-03-18 2015-05-21 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ヒト・パピローマウイルスに対するワクチン接種方法
CN108276491B (zh) * 2018-02-05 2021-01-12 南京薇熙生物医药科技有限公司 一种可特异性识别hpv18 l1蛋白的单克隆抗体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
DE4015044A1 (de) * 1990-05-10 1991-11-14 Behringwerke Ag Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
DE122007000085I1 (de) * 1991-07-19 2008-03-27 Univ Queensland St Lucia Polynukleotidabschnitt des HPV16-Genoms
DE122007000098I1 (de) * 1992-06-25 2008-03-27 Papillomavirus vakzine
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
DE122007000014I1 (de) * 1993-03-09 2007-05-24 Univ Rochester Herstellung von menschlichem Papillomavirus Hüllprotein und virus-ähnlichen Teilchen

Also Published As

Publication number Publication date
WO1996029413A2 (en) 1996-09-26
PT817851E (pt) 2004-06-30
HU223761B1 (hu) 2005-01-28
AU714533B2 (en) 2000-01-06
DE122007000030I1 (de) 2007-07-19
DE122007000031I1 (de) 2007-07-19
EP0817851B1 (en) 2004-02-18
HUP9801334A2 (hu) 1998-08-28
CN1100876C (zh) 2003-02-05
NO322254B1 (no) 2006-09-04
WO1996029413A3 (en) 1996-11-28
ATE259879T1 (de) 2004-03-15
HUP9801334A3 (en) 1999-04-28
CZ291242B6 (cs) 2003-01-15
JPH11502704A (ja) 1999-03-09
DK0817851T3 (da) 2004-08-16
NL300272I1 (nl) 2007-05-01
DE69631586D1 (de) 2004-03-25
KR100430698B1 (ko) 2004-07-15
NZ305188A (en) 1999-11-29
NL300271I1 (nl) 2007-05-01
DE69631586T9 (de) 2005-06-16
PL184022B1 (pl) 2002-08-30
NO974322D0 (no) 1997-09-19
EP0817851A2 (en) 1998-01-14
CA2215834A1 (en) 1996-09-26
IL117459A0 (en) 1996-07-23
NL300273I1 (nl) 2007-05-01
FR07C0023I2 (fr) 2012-08-03
SK127897A3 (en) 1998-07-08
DK0817851T5 (da) 2004-10-25
CA2215834C (en) 2007-06-12
DE69631586T2 (de) 2005-01-27
NO974322L (no) 1997-11-24
DE122007000025I1 (de) 2007-07-12
FR07C0023I1 (xx) 2007-04-27
EP1422294A1 (en) 2004-05-26
EA001092B1 (ru) 2000-10-30
CZ293697A3 (cs) 1998-02-18
AU5314196A (en) 1996-10-08
MX9707208A (es) 1997-11-29
CN1185176A (zh) 1998-06-17
PL322333A1 (en) 1998-01-19
EP0817851B9 (en) 2004-08-18
SK284281B6 (sk) 2004-12-01
EA199700256A1 (ru) 1999-06-24
ES2213772T3 (es) 2004-09-01

Similar Documents

Publication Publication Date Title
NL300273I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
HUP9801608A3 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
BG100974A (en) Vaccines against papillomavirus
ZA962245B (en) Dna encoding human papillomavirus type 18
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
ZA976326B (en) Analogs of cationic proteins.
DE69534778D1 (en) Cathepsin-02-protease
GB9207701D0 (en) Papillomavirus e7 protein
CA2200582A1 (en) Dna encoding human papillomavirus type 6a
EP0990703A4 (en) NEW POLYPEPTIDE, FOR CODING DNA AND THEIR USE
AU3711597A (en) A novel galanin receptor
ZA966489B (en) New protein human MP52 Arg.
TR199501328A2 (tr) Alzheimer peptidi.
CA2194032A1 (en) Fused dna sequence, fused protein expressed from said fused dna sequence and method for expressing said fused protein
AU6456096A (en) Lysine 1689 factor viii:c polypeptide analogs
ZA929176B (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b e)azepine-6,11-dione-11-oximes.
MX9707457A (es) Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
ES2191785T3 (es) Proteina de accion antitumoral.
ZA964358B (en) "DNA encoding cellular homologue of the SV40 Large T antigen".
CA2216827A1 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
HUT65363A (en) Midole-ripening, well productiv much aleurone containing bread-wheat "gk zugoly" (triticum aestivum l.)
IT238648Y1 (it) Pedale per l'azionamento di valvole pneumatiche o di interruttorielettrici
AUPN579395A0 (en) Improved powered walking assistant
ZA961162B (en) Mutant proteins.
ITRM940330A0 (it) "procedimento migliorato per la preparazione della 14b-idrossi-etianaldeide".

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
EXTF Application for patent extension filed
EXTF Application for patent extension filed
KB Patent renewed
PEL Intention of commissioner to extend period of protection

Free format text: PRODUCT NAME: PROTEIN L1 (TYPE 18

Extension date: 20170719

ERR Corrigendum

Free format text: NO. OF JOURNAL WHERE THE ERROR WAS PUBLISHED: 12/2014 04/2015 THE REQUESTED CORRECTION: NAME OF APPLICANT: PFIZER PRODUCTS, INC. OSI PHARMACEUTICALS, LLC

EXTG Extension of patent term granted

Extension date: 20170719

EXTN Extension order renewed